Skip to content
SPACListing
CompletedNYSE

Claritev CorpCTEV

Class A CTEVCIK 0001793229

Cash in trust

$1.1B

$1,104,025,998

Trust per share

$10.00

Redemption value

IPO

Feb 2020

$1.1B raised

Combination deadline

—

Not disclosed

Filings on record

533

Latest Oct 27, 2026

Business combination

Target
Not disclosed in an indexed filing
Announced
Jul 31, 2020
Closed
Oct 9, 2020

Overview

Claritev Corp is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001793229. It completed its initial public offering in Feb 2020, raising $1.1B in gross proceeds and listing on NYSE. Class A shares trade under the ticker CTEV on NYSE. The vehicle is sponsored by Churchill Capital through Churchill Sponsor III LLC. The mandate targets financial services. Business combination closed; the company trades under a new ticker.

“Our strategy is to: • leverage the strategic and transactional experience of our founder to bring advice and attention to potential business combination targets; • deliver creative approaches to transaction sourcing; and • utilize an understanding of global financial markets and events, financing, and overall corporate strategy options.”
The mandate, as stated in the IPO prospectus

Reading the filings

Arithmetic on what Claritev Corp has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.

  • Trust versus the $10 unit

    The trust holds $10.00 per public share, effectively the $10.00 the units were sold at, so little or no interest has accrued to the account yet.

  • Warrant coverage

    Each unit carried one-fourth warrant per unit. Warrants are dilution deferred: they cost the holder nothing until exercised, and they overhang the post-combination share count. Thinner coverage is generally a sign of a stronger book at pricing.

  • Sponsor record

    Churchill Capital has launched 12 vehicles. Of the 8 that have resolved, 7 closed a combination and 1 liquidated, a 87.5% completion rate. A sponsor's record is not a forecast, but it does tell you whether the team has taken a deal across the line before.

  • Underwriting

    Citigroup led the offering. It has been named on 170 SPAC IPOs, book-running 114 of them, and 53.6% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.

How busy it has been

Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.

412102019-122026-10

533 filings in all. 22 in the last three months, against a busiest month of 41.

News on Claritev Corp

Last 90 days

SEC filing history

Free tier: filings older than 24 hours
  • 4

    Statement of changes in beneficial ownership

    Accession 0001104659-26-119180

    Oct 27, 2026

    4d ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001104659-26-119177

    Oct 27, 2026

    4d ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002159146-26-000005

    Oct 19, 2026

    12d ago

    View on EDGAR ↗
  • 3

    Initial statement of beneficial ownership

    Accession 0002159146-26-000003

    Oct 19, 2026

    12d ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002041258-26-000006

    Oct 16, 2026

    15d ago

    View on EDGAR ↗
  • 144

    144 filing

    Accession 0001950047-26-010268

    Oct 15, 2026

    16d ago

    View on EDGAR ↗
  • 8-K

    Regulation FD disclosure

    Items 5.02, 7.01, 9.01 · Accession 0001793229-26-000077

    Oct 15, 2026

    17d ago

    View on EDGAR ↗
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001140361-26-038318

    Oct 2, 2026

    1mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002032799-26-000008

    Sep 22, 2026

    1mo ago

    View on EDGAR ↗
  • 144

    144 filing

    Accession 0001950047-26-009699

    Sep 21, 2026

    1mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002153513-26-000007

    Sep 16, 2026

    1mo ago

    View on EDGAR ↗
  • 3

    Initial statement of beneficial ownership

    Accession 0002153513-26-000006

    Sep 16, 2026

    1mo ago

    View on EDGAR ↗
  • 8-K

    Regulation FD disclosure

    Items 5.02, 7.01, 9.01 · Accession 0001793229-26-000071

    Sep 15, 2026

    1mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001628280-26-059472

    Aug 31, 2026

    2mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002041258-26-000004

    Aug 18, 2026

    2mo ago

    View on EDGAR ↗
  • 144

    144 filing

    Accession 0001950047-26-008188

    Aug 14, 2026

    2mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002033015-26-000006

    Aug 12, 2026

    2mo ago

    View on EDGAR ↗
  • 144

    144 filing

    Accession 0001950047-26-007921

    Aug 10, 2026

    2mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002033015-26-000004

    Aug 7, 2026

    2mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002032799-26-000006

    Aug 7, 2026

    2mo ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001793229-26-000067

    Aug 7, 2026

    2mo ago

    View on EDGAR ↗
  • 8-K

    Current report

    Items 2.02, 9.01 · Accession 0001793229-26-000065

    Aug 7, 2026

    2mo ago

    View on EDGAR ↗
  • 8-K

    Other events

    Item 8.01 · Accession 0001793229-26-000061

    Jul 6, 2026

    3mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001636355-26-000009

    Jul 2, 2026

    4mo ago

    View on EDGAR ↗
  • 8-K

    Regulation FD disclosure

    Item 7.01 · Accession 0001793229-26-000056

    Jun 22, 2026

    4mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001962112-26-000007

    Jun 10, 2026

    4mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001828369-26-000014

    May 19, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001982656-26-000004

    May 19, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001841409-26-000007

    May 19, 2026

    5mo ago

    View on EDGAR ↗
  • 8-K

    Regulation FD disclosure

    Item 7.01 · Accession 0001793229-26-000052

    May 18, 2026

    5mo ago

    View on EDGAR ↗

Pro

Track CTEV without the delay

Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.

  • Filings live, no 24-hour delay
  • One click through to the source document
  • Deadline calendar out to 12 months
  • CSV export, API and MCP access

Cancel any time. Billed monthly in USD.

Claritev Corp: questions answered

What is Claritev Corp (CTEV)?

Claritev Corp is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001793229. It completed its initial public offering in Feb 2020, raising $1.1B in gross proceeds and listing on NYSE. Class A shares trade under the ticker CTEV on NYSE. The vehicle is sponsored by Churchill Capital through Churchill Sponsor III LLC. The mandate targets financial services. Business combination closed; the company trades under a new ticker.

How much does Claritev Corp hold in trust?

Approximately $1,104,025,998, or about $10.00 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.

When must Claritev Corp complete a merger?

No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.

What happens if Claritev Corp does not find a target in time?

The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.

Can I redeem shares in Claritev Corp, and at what price?

Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $10.00 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.

What tickers does Claritev Corp trade under?

Class A shares trade as CTEV on NYSE. Units trade first and separate into their component securities roughly 52 days after the IPO; only the Class A shares carry the redemption right against the trust.

Is the trust value the same as the share price for Claritev Corp?

No, and the gap between them is the whole trade. Trust per share is a disclosed, contractual figure of $10.00, being what a redeeming holder receives. The market price is whatever the shares change hands at: most recently $24.00, a spread to the redemption value. Quotes on this site are delayed and indicative; confirm on your own venue before trading.

How much dilution do Claritev Corp's founder shares and warrants create?

Each unit also carried one-fourth warrant per unit, which is dilution deferred until exercise. Both are disclosed in the prospectus and both survive into the combined company, which is why a de-SPAC at $10 is not economically the same as an IPO at $10.

Who sponsors Claritev Corp, and what is their track record?

Churchill Sponsor III LLC is the sponsor entity, part of the Churchill Capital franchise. That franchise has launched 12 vehicles in total, of which 7 closed a combination and 1 liquidated, a 87.5% completion rate on resolved vehicles. Named principals: Michael Klein.

Which banks underwrote the Claritev Corp IPO?

Citigroup, Goldman Sachs, Maxim Group. Syndicate membership and role are read from the prospectus cover and the underwriting section.

Is Claritev Corp tradeable, and where?

Yes. CTEV returned a live quote of $24.00 on NYSE. Quotes here are delayed and refreshed on a schedule rather than streamed, so treat the figure as indicative and confirm on your own venue. Units and warrants trade under their own symbols and are quoted separately.

Is Claritev Corp a good investment?

That is not a question this site answers. Claritev Corp is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.

Where does this Claritev Corp data come from?

Filings Claritev Corp submitted to the SEC under CIK 0001793229: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.

Compiled by the SPACListing research desk

Last reconciled Nov 1, 2026

Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.

Read the full methodology · What is in the dataset · Report a correction

SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.

Continue reading

The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.